The Peptide Testing Boom: Labs Flag Quality Failures as Unregulated Injections Flood the Market

The Underground Peptide Market Is Growing Fast — and So Are the Risks

Across the UK and beyond, thousands of people are injecting unregulated substances purchased online, hoping to shed weight, heal faster, or slow the aging process. The compounds in question are peptides — short chains of amino acids that have captured mainstream attention largely off the back of blockbuster weight-loss drugs like Wegovy. But as demand surges, so do serious concerns about safety, quality, and the complete absence of regulatory oversight.

To get a sense of just how quickly this market has grown, consider one telling data point: a decade ago, peptide testing laboratories around the world handled only a small handful of customer submissions each month. Today, some are processing tens of thousands of samples annually.

Testing Demand Has Skyrocketed

Finnrick, a peptide-testing laboratory based in Texas, has witnessed this explosion firsthand. The lab — which typically purchases peptide products through the same online channels used by everyday consumers rather than accepting samples directly from vendors — now analyses thousands of products. Its findings are sobering: approximately one in three items tested fails basic quality control standards. That failure rate has remained largely consistent over the 12 to 14 months the lab has been systematically tracking the data.

In June of last year, Finnrick expanded its service to accept submissions from members of the public, reflecting growing consumer appetite for independent verification. Any samples submitted directly by vendors are clearly flagged on the lab's website to maintain transparency.

Janoshik Analytical, a laboratory in the Czech Republic with a strong reputation for testing peptides and performance-enhancing compounds, has seen similarly dramatic growth. Peter Magic, a chemist at the lab, says monthly sample volumes have now climbed to around 5,000 — a number that would have seemed extraordinary just a few years ago.

"Roughly three or four years ago, there was an exponential rise in demand, mostly for peptides," Magic explained, pointing to the mainstream arrival of highly effective GLP-1 receptor agonist drugs as the primary catalyst. "Especially with the advent of semaglutide, we saw an insane explosion in interest — then tirzepatide, and now retatrutide, which is the most modern compound currently available."

Retatrutide is a weight-loss medication still undergoing clinical trials and not yet approved for use in the UK, meaning its sale and supply is currently illegal.

What Exactly Are People Injecting?

The substances driving this trend range from black-market versions of approved medications to entirely experimental compounds championed by the biohacking and anti-aging communities. Some are essentially counterfeit equivalents of prescription drugs — such as semaglutide, the active ingredient in Wegovy, or tirzepatide, found in the weight-loss injection Mounjaro — available online for a fraction of what a legitimate prescription would cost.

Others are experimental peptides with no approved medical use, promoted heavily on platforms like TikTok and Telegram. Advocates claim these injections can accelerate injury recovery, enhance cognitive performance, and reduce visible signs of aging. However, the scientific evidence supporting most of these claims remains thin or entirely absent.

A key reason these substances circulate so freely is a legal loophole. Many are sold under labels stating they are "for research purposes only," and because some are not formally classified as medicines, vendors operate in a regulatory grey zone with minimal scrutiny from authorities.

The UK Is a Major Player in This Global Market

Magic noted that while the United States and China dominate overall market volume, the UK ranks alongside Canada in third place globally, accounting for roughly 2,000 testing orders submitted to Janoshik since 2024 alone.

"The UK is a rather significant peptide market," he said. "It's a populous country, and the peptide market is closely intertwined with performance-enhancing drug culture — often sharing the same factories, the same vendors, and the same distribution networks."

TikTok data reinforces the UK's prominent role. An analysis of more than 5,000 peptide-related videos found that while 64% originated from US-based accounts, UK creators were the second largest group, responsible for 16% of the content.

Experts Sound the Alarm

Health and regulatory experts are urging caution in the strongest possible terms. Dr. Luke Turnock, a senior lecturer in criminology at the University of Lincoln, highlighted the fundamental problem facing consumers: there is often no reliable way to know whether a purchased product actually contains what it claims to, or whether the dosage is accurate.

"There are risks that you don't necessarily know that what you think you're buying is in fact the product it claims to be," he said. "And you don't know if it's overdosed or underdosed."

Professor Amira Guirguis, Chief Scientist at the Royal Pharmaceutical Society, pointed to a structural gap in how these products are marketed and sold. "Websites that sell peptides in a retail-style way, often with labels like 'research use only', sit outside the usual controlled systems," she said. "Where substances have biological effects — or when introduced into the body can alter one or more physiological functions — questions about oversight, traceability, and quality assurance become absolutely vital."

A Market Moving Faster Than Regulation

The peptide craze represents a broader challenge for public health authorities: an unregulated market growing at speed, fuelled by social media hype, consumer desperation for affordable weight-loss solutions, and a legal framework that has struggled to keep pace. Until regulators close existing loopholes and introduce clearer oversight, consumers purchasing these substances are, in effect, running their own uncontrolled experiments — with their own bodies as the test subjects.